New FDA compliance policies for fish and fishery products
USA
Nov 08, 2024
The U.S. Food and Drug Administration (FDA) is announcing the availability of a final Compliance Policy Guide (CPG) intended to provide the FDA’s current thinking on the adulteration of fish and fishery products with Scombrotoxin (histamine).
The CPG, titled “Sec. 540.525 Scombrotoxin (Histamine)-forming Fish and Fishery Products – Decomposition and Histamine (CPG 7108.24) Compliance Policy Guide” will assist the FDA in addressing adulteration associated with decomposition and histamine identified during surveillance sampling and testing. It also will increase consumer protections related to scombrotoxin (histamine) fish poisoning (SFP) by lowering the levels of histamine in fish at which the FDA indicates that it may take action.
For further information (in English), click on the Link